For the roughly 150,000 AIDS patients who come down with a life-threatening infection called fungal meningitis each year, there aren’t many options.
FDA encourages collaboration between monoclonal antibody sponsors to keep pace with emerging Covid variants
The FDA is encouraging developers of Covid-19 monoclonal antibodies to collaborate and better target emerging variants in final guidance published on Wednesday. The regulator explained